The Significance of Funguria in Hospitalized Patients (FACES)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00787085|
Recruitment Status : Completed
First Posted : November 7, 2008
Last Update Posted : November 7, 2008
|Condition or disease|
|Urinary Tract Infections|
A recent large multi-center national surveillance survey of almost 5000 nosocomial (hospital based) urine isolates from medical intensive care units demonstrated that fungi comprised nearly 40% of urine isolates. Little is known about distinguishing fungi that cause colonization from those causing infection.
The objective of this study is to define the epidemiology of nosocomial funguria and natural history of patients that develop funguria while hospitalized.
Patients who may have eligible for this study will be identified from microbiology laboratory specimens at the Harbor-UCLA Medical Center and Cedars-Sinai Medical Center.
|Study Type :||Observational|
|Actual Enrollment :||919 participants|
|Observational Model:||Case Control|
|Official Title:||The Significance of Funguria in Hospitalized Patients (FACES)|
|Study Start Date :||September 2001|
|Primary Completion Date :||February 2006|
|Study Completion Date :||February 2006|
Patients hospitalized with a urine or blood culture positive for fungi
Patients hospitalized with a urine culture negative for fungi
- Funguria [ Time Frame: Hospitalization day 0, 3, 7, 14, and every 7 days thereafter until hospital discharge or death ]
Biospecimen Retention: Samples Without DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00787085
|United States, California|
|Cedars-Sinai Medical Center|
|Los Angeles, California, United States, 90048|
|Harbor-UCLA Medical Center|
|Torrance, California, United States, 90509|
|Principal Investigator:||Loren G Miller, M.D., M.P.H.||Los Angeles Biomedical Research Institute|